Jaguar Health (JAGX) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Jaguar Health (JAGX) over the last 9 years, with Q3 2025 value amounting to -$6.28.
- Jaguar Health's EPS (Weighted Average and Diluted) rose 7611.26% to -$6.28 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.21, marking a year-over-year increase of 9950.37%. This contributed to the annual value of -$130.69 for FY2024, which is 9512.03% up from last year.
- According to the latest figures from Q3 2025, Jaguar Health's EPS (Weighted Average and Diluted) is -$6.28, which was up 7611.26% from -$10.26 recorded in Q2 2025.
- Over the past 5 years, Jaguar Health's EPS (Weighted Average and Diluted) peaked at $0.44 during Q4 2022, and registered a low of -$594.64 during Q4 2023.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$51.23, with a median of -$10.26 in 2025.
- Per our database at Business Quant, Jaguar Health's EPS (Weighted Average and Diluted) skyrocketed by 10050.37% in 2022 and then plummeted by 13524628.81% in 2023.
- Over the past 5 years, Jaguar Health's EPS (Weighted Average and Diluted) (Quarter) stood at -$87.35 in 2021, then soared by 100.5% to $0.44 in 2022, then tumbled by 135246.29% to -$594.64 in 2023, then soared by 94.16% to -$34.75 in 2024, then soared by 81.93% to -$6.28 in 2025.
- Its EPS (Weighted Average and Diluted) was -$6.28 in Q3 2025, compared to -$10.26 in Q2 2025 and -$16.7 in Q1 2025.